Evaluation of the Washington Intensive Supervision Program

April 6, 2018 updated by: Brett T. Leach, Pepperdine University
This study entails an evaluation of the Washington Intensive Supervision Program (WISP). The purpose of the evaluation is to test whether subjects assigned to WISP perform better than those assigned to parole-as-usual (PAU).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study entails an evaluation of the Washington Intensive Supervision Program (WISP). WISP is a program targeting high-risk parolees in Seattle, and is modeled after the HOPE program in Hawaii. The purpose of the evaluation is to test whether subjects assigned to WISP perform better than those assigned to parole-as-usual (PAU) on a number of outcomes, including drug use, missed appointments, recidivism, prison and jail stays, and parole revocations. WISP uses regular random drug testing and close community supervision, paired with swift and certain, but modest sanctions for every detected violation.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Washington
      • Seattle, Washington, United States
        • Seattle Community Justice Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Inmates released by DOC to community corrections supervision
  • Supervised out of the Seattle CJC (Community Justice Center) to include field offices and offenders from the downtown "Metro" unit, Southeast Seattle unit, Northgate (north Seattle) and West Seattle.
  • Have a parole supervision discharge date at least one year from the date of release from entry into WISP

Exclusion Criteria:

  • Level III Sex Offenders
  • Existing assignment to supervision that precludes WISP. These include: Drug Offender Sentencing Alternative (DOSA)and Special Sex Offender Sentencing Alternative (SSOSA).
  • Dangerously Mentally Ill (DMIO)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: WISP supervision
Parolee supervised under WISP parole model.
Behavioral: WISP supervision
WISP entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). WISP includes regular random drug testing.
Other Names:
  • HOPE supervision
ACTIVE_COMPARATOR: Parole-as-usual
Parolees supervised under Washington State's parole-as-usual
Behavioral: Parole-as-usual
Parolees are supervised under standard parole supervision practice in Washington State.
Other Names:
  • PAU

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Revocation rate
Time Frame: 12 months
Percentage of subjects in each condition who are revoked from parole and returned to prison
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
% positive drug tests
Time Frame: 12 months
Percentage of random and scheduled drug tests that test positive for illicit drugs
12 months
Days incarcerated
Time Frame: 12 months
Total number of days incarcerated in jail or prison
12 months
% Missed appointments
Time Frame: 12 months
Percentage of parole appointments that are missed.
12 months
New arrests
Time Frame: 12 months
Number of new arrests.
12 months
Assessed risk
Time Frame: 12 months
Parolee risk assessment (high, medium, low)
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Pepperdine University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (ACTUAL)

January 1, 2012

Study Completion (ACTUAL)

June 1, 2012

Study Registration Dates

First Submitted

April 26, 2011

First Submitted That Met QC Criteria

April 27, 2011

First Posted (ESTIMATE)

April 28, 2011

Study Record Updates

Last Update Posted (ACTUAL)

April 10, 2018

Last Update Submitted That Met QC Criteria

April 6, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • SPP0311F08

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Behavior

Clinical Trials on WISP supervision

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe